Company Filing History:
Years Active: 2008
Title: Francesco Granata: Innovator in Cardiac Therapy
Introduction
Francesco Granata is a notable inventor based in Milan, Italy. He has made significant contributions to the field of cardiac therapy through his innovative research and patents. His work focuses on the therapeutic prevention and treatment of heart diseases, particularly cardiac insufficiency and heart failure.
Latest Patents
Francesco Granata holds a patent for a method involving essential n-3 fatty acids in the treatment of heart diseases. The patent, titled "Essential n-3 fatty acids in cardiac insufficiency and heart failure therapy," describes a method that includes the administration of a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA). This method can be used alone or in combination with other therapeutic agents to effectively address heart conditions.
Career Highlights
Francesco Granata is currently associated with Pfizer Italia S.r.l., where he continues to advance his research in cardiac health. His work has been instrumental in developing new therapeutic approaches that can improve patient outcomes in heart disease management.
Collaborations
Francesco has collaborated with esteemed colleagues such as Franco Pamparana and Eduardo Stragliotto. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful advancements in medical therapies.
Conclusion
Francesco Granata's contributions to cardiac therapy through his patent and work at Pfizer Italia S.r.l. highlight his commitment to improving heart health. His innovative approach to using essential fatty acids in treatment showcases the potential for new therapeutic strategies in managing heart diseases.